annual CFI:
-$403.00K+$271.00K(+40.21%)Summary
- As of today (June 28, 2025), APLS annual cash flow from investing activities is -$403.00 thousand, with the most recent change of +$271.00 thousand (+40.21%) on December 31, 2024.
- During the last 3 years, APLS annual CFI has fallen by -$248.02 million (-100.16%).
- APLS annual CFI is now -100.16% below its all-time high of $247.62 million, reached on December 31, 2021.
Performance
APLS Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$8000.00+$12.00K(+60.00%)Summary
- As of today (June 28, 2025), APLS quarterly cash flow from investing activities is -$8000.00, with the most recent change of +$12.00 thousand (+60.00%) on March 31, 2025.
- Over the past year, APLS quarterly CFI has increased by +$285.00 thousand (+97.27%).
- APLS quarterly CFI is now -100.00% below its all-time high of $198.76 million, reached on September 30, 2020.
Performance
APLS quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$118.00K+$285.00K(+70.72%)Summary
- As of today (June 28, 2025), APLS TTM cash flow from investing activities is -$118.00 thousand, with the most recent change of +$285.00 thousand (+70.72%) on March 31, 2025.
- Over the past year, APLS TTM CFI has increased by +$590.00 thousand (+83.33%).
- APLS TTM CFI is now -100.04% below its all-time high of $331.58 million, reached on March 31, 2023.
Performance
APLS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
APLS Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.2% | +97.3% | +83.3% |
| 3 y3 years | -100.2% | +100.0% | -100.1% |
| 5 y5 years | +76.2% | +100.0% | +100.0% |
APLS Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.2% | +40.2% | -100.0% | +100.0% | -100.0% | +83.3% |
| 5 y | 5-year | -100.2% | +99.9% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -100.2% | +99.9% | -100.0% | +100.0% | -100.0% | +100.0% |
APLS Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$8000.00(-60.0%) | -$118.00K(-70.7%) |
| Dec 2024 | -$403.00K(-40.2%) | -$20.00K(<-9900.0%) | -$403.00K(+6.3%) |
| Sep 2024 | - | $0.00(-100.0%) | -$379.00K(-11.0%) |
| Jun 2024 | - | -$90.00K(-69.3%) | -$426.00K(-39.8%) |
| Mar 2024 | - | -$293.00K(-7425.0%) | -$708.00K(+5.0%) |
| Dec 2023 | -$674.00K(-101.1%) | $4000.00(-108.5%) | -$674.00K(-100.5%) |
| Sep 2023 | - | -$47.00K(-87.4%) | $123.45M(-50.3%) |
| Jun 2023 | - | -$372.00K(+43.6%) | $248.28M(-25.1%) |
| Mar 2023 | - | -$259.00K(-100.2%) | $331.58M(+453.6%) |
| Dec 2022 | $59.89M(-75.8%) | $124.13M(-0.5%) | $59.89M(+188.7%) |
| Sep 2022 | - | $124.78M(+50.5%) | $20.74M(-72.6%) |
| Jun 2022 | - | $82.93M(-130.5%) | $75.61M(-38.2%) |
| Mar 2022 | - | -$271.95M(-420.0%) | $122.43M(-50.6%) |
| Dec 2021 | $247.62M | $84.98M(-52.7%) | $247.62M(+52.3%) |
| Sep 2021 | - | $179.65M(+38.5%) | $162.54M(-10.5%) |
| Jun 2021 | - | $129.75M(-188.4%) | $181.66M(-177.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$146.76M(>+9900.0%) | -$235.90M(-25.6%) |
| Dec 2020 | -$316.99M(>+9900.0%) | -$91.00K(-100.0%) | -$316.99M(-0.0%) |
| Sep 2020 | - | $198.76M(-169.1%) | -$317.05M(-38.6%) |
| Jun 2020 | - | -$287.81M(+26.3%) | -$516.29M(+125.8%) |
| Mar 2020 | - | -$227.85M(>+9900.0%) | -$228.67M(>+9900.0%) |
| Dec 2019 | -$1.69M(<-9900.0%) | -$155.00K(-67.1%) | -$1.69M(+10.1%) |
| Sep 2019 | - | -$471.00K(+145.3%) | -$1.54M(+44.1%) |
| Jun 2019 | - | -$192.00K(-78.1%) | -$1.07M(+21.9%) |
| Mar 2019 | - | -$875.00K(<-9900.0%) | -$875.00K(<-9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $0.00(-100.0%) | - | - |
| Dec 2014 | -$19.90K(<-9900.0%) | - | - |
| Dec 2013 | $0.00 | - | - |
FAQ
- What is Apellis Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual CFI year-on-year change?
- What is Apellis Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly CFI year-on-year change?
- What is Apellis Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM CFI year-on-year change?
What is Apellis Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of APLS is -$403.00K
What is the all time high annual CFI for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual cash flow from investing activities is $247.62M
What is Apellis Pharmaceuticals annual CFI year-on-year change?
Over the past year, APLS annual cash flow from investing activities has changed by +$271.00K (+40.21%)
What is Apellis Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of APLS is -$8000.00
What is the all time high quarterly CFI for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly cash flow from investing activities is $198.76M
What is Apellis Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, APLS quarterly cash flow from investing activities has changed by +$285.00K (+97.27%)
What is Apellis Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of APLS is -$118.00K
What is the all time high TTM CFI for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM cash flow from investing activities is $331.58M
What is Apellis Pharmaceuticals TTM CFI year-on-year change?
Over the past year, APLS TTM cash flow from investing activities has changed by +$590.00K (+83.33%)